homefeedbacksupportlog on 9-Feb-2010 
  Search
 
   
 
  Browse
ALL OF MEDICINE

Cardiovascular Disorders
Related Sections

profile subject selected for My F1000

Browse > Cardiovascular Disorders
Current Top 10 by F1000 Factor / All Time Top 10 by F1000 Factor / Most viewed
(from all journals)
/ Most viewed
(from specialty journals)
/ Hidden jewels
Page 10 of 33. Select Page: << 6 7 8 9 10 11 12 13 14 15 >>
Display 10 / 20 / 50 papers per page

printer friendly 
to email [Help]

Recommended
F1000 Factor 3.0

Confirmation
New Finding
Neuronal nitric oxide synthase protects against myocardial infarction-induced ventricular arrhythmia and mortality in mice.
Burger DE, Lu X, …, Sims SM, Feng Q
Circulation 2009 Oct 6 120(14):1345-54 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Andreas Goette
Evaluated 4 Nov 2009

Must Read
F1000 Factor 6.0

New Finding
Atypical antipsychotic drugs and the risk of sudden cardiac death.
Ray WA, Chung CP, …, Hall K, Stein CM
N Engl J Med 2009 Jan 15 360(3):225-35 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Diler Acar and Kirk Daffner
Evaluated 4 Nov 2009


Recommended
F1000 Factor 3.0

Confirmation
Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator.
Roes SD, Borleffs CJ, …, Schalij MJ, Bax JJ
Circ Cardiovasc Imaging 2009 May 2(3):183-90 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Christopher Kramer
Evaluated 3 Nov 2009

Recommended
F1000 Factor 3.0

Confirmation
Tech Advance
Surgical treatment of patients enrolled in the national registry of genetically triggered thoracic aortic conditions.
Song HK, Bavaria JE, …, LeMaire SA, National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions (GenTAC) Consortium
Ann Thorac Surg 2009 Sep 88(3):781-7; discussion 787-8 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Michael Andritsos and John Augoustides
Evaluated 3 Nov 2009

Recommended
F1000 Factor 3.0

Hypothesis
Reducing false alarm rates for critical arrhythmias using the arterial blood pressure waveform.
Aboukhalil A, Nielsen L, …, Mark RG, Clifford GD
J Biomed Inform 2008 Jun 41(3):442-51 [abstract on PubMed] [related articles] [FREE full text]
Selected by | Noa Segall and Melanie Wright
Evaluated 2 Nov 2009

Recommended
F1000 Factor 3.0

Confirmation
Percutaneous left atrial appendage occlusion for patients in atrial fibrillation suboptimal for warfarin therapy: 5-year results of the PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) Study.
Block PC, Burstein S, …, Williams DO, Reisman M
JACC Cardiovasc Interv 2009 Jul 2(7):594-600 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Saif Anwaruddin and Samir Kapadia
Evaluated 2 Nov 2009

Recommended
F1000 Factor 3.0

Confirmation
Tech Advance
Can balloon aortic valvuloplasty help determine appropriate transcatheter aortic valve size?
Babaliaros VC, Liff D, …, Green JT, Block PC
JACC Cardiovasc Interv 2008 Oct 1(5):580-6 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Harish Ramakrishna and John Augoustides
Evaluated 2 Nov 2009

Recommended
F1000 Factor 3.0

Confirmation
Has there been any progress made on pregnancy outcomes among women with pulmonary arterial hypertension?
Bédard E, Dimopoulos K, Gatzoulis MA
Eur Heart J 2009 Feb 30(3):256-65 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Matthias Greutmann and Candice Silversides
Evaluated 2 Nov 2009

Recommended
F1000 Factor 3.0

Confirmation
New Finding
Hereditary deficiency of gp91(phox) is associated with enhanced arterial dilatation: results of a multicenter study.
Violi F, Sanguigni V, …, Basili S, Loffredo L
Circulation 2009 Oct 20 120(16):1616-22 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Melanie E Armitage, Kirstin Wingler and Harald HHW Schmidt
Evaluated 30 Oct 2009

Must Read
F1000 Factor 6.0

Hypothesis
Cell death.
Hotchkiss RS, Strasser A, McDunn JE, Swanson PE
N Engl J Med 2009 Oct 15 361(16):1570-83 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Jerrold Levy
Evaluated 30 Oct 2009

Recommended
F1000 Factor 3.0

New Finding
Combination of Captopril and Allopurinol Retards Fructose-Induced Metabolic Syndrome.
Roncal CA, Reungjui S, …, Nakagawa T, Johnson RJ
Am J Nephrol 2009 Aug 21 30(5):399-404 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Mony Fraer and Bradley Dixon
Evaluated 30 Oct 2009

Recommended
F1000 Factor 3.0

Confirmation
Risk factors and mode of death in isolated hypertrophic cardiomyopathy in children.
Decker JA, Rossano JW, …, Towbin JA, Denfield SW
J Am Coll Cardiol 2009 Jul 14 54(3):250-4 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Willem Helbing
Evaluated 29 Oct 2009

Must Read
F1000 Factor 6.0

Confirmation
New Finding
Tech Advance
Reduced incidence and severity of acute mountain sickness in Qinghai-Tibet railroad construction workers after repeated 7-month exposures despite 5-month low altitude periods.
Wu TY, Ding SQ, …, Sun YF, Kayser B
High Alt Med Biol 2009 10(3):221-32 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Robert Schoene
Evaluated 29 Oct 2009

Recommended
F1000 Factor 3.0

Confirmation
Prevalence of acute mountain sickness in the Eastern Alps.
Mairer K, Wille M, Bucher T, Burtscher M
High Alt Med Biol 2009 10(3):239-45 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Robert Schoene
Evaluated 29 Oct 2009

Recommended
F1000 Factor 3.0

Confirmation
Effect of six days of staging on physiologic adjustments and acute mountain sickness during ascent to 4300 meters.
Beidleman BA, Fulco CS, …, Brothers MD, Cymerman A
High Alt Med Biol 2009 10(3):253-60 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Robert Schoene
Evaluated 29 Oct 2009

Recommended
F1000 Factor 3.0

New Finding
Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study.
Schwartz N, Rubinstein T, …, Michaelson JS, Putterman C
Arthritis Res Ther 2009 Sep 28 11(5):R143 [abstract on PubMed] [related articles] [FREE full text]
Selected by | Neeraj Dhaun and David Kluth
Evaluated 28 Oct 2009

Recommended
F1000 Factor 3.0

Controversial
Potential clinical and economic consequences of noncardiac incidental findings on cardiac computed tomography.
Machaalany J, Yam Y, …, Beanlands RS, Chow BJ
J Am Coll Cardiol 2009 Oct 13 54(16):1533-41 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Chesnal D Arepalli and Arthur Stillman
Evaluated 28 Oct 2009

Recommended
F1000 Factor 3.0

Confirmation
Life expectancy in relation to cardiovascular risk factors: 38 year follow-up of 19,000 men in the Whitehall study.
Clarke R, Emberson J, …, Marmot M, Shipley MJ
BMJ 2009 339:b3513 [abstract on PubMed] [related articles] [FREE full text]
Selected by | Anders Olsson
Evaluated 28 Oct 2009

Recommended
F1000 Factor 3.0

New Finding
Effects of rosuvastatin on atrial fibrillation occurrence: ancillary results of the GISSI-HF trial.
Maggioni AP, Fabbri G, …, Tavazzi L, GISSI-HF Investigators
Eur Heart J 2009 Oct 30(19):2327-36 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Juan Tamargo
Evaluated 28 Oct 2009

Must Read
F1000 Factor 6.4

New Finding
Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study.
Pedersen LH, Henriksen TB, …, Olsen J, Bech BH
BMJ 2009 339:b3569 [abstract on PubMed] [related articles] [FREE full text]
Selected by | Deborah Kim / B Robinson Williams III and Nanette Wenger
First evaluation 28 Oct 2009 | Latest evaluation 24 Dec 2009


top of pagePage 10 of 33. Select Page: << 6 7 8 9 10 11 12 13 14 15 >>
Display 10 / 20 / 50 papers per page



© 2010 Medicine Reports Ltd unless otherwise stated. < info@f1000.com >   Terms and conditions   Legal info